We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.17B
AUM Growth
-$346M
Cap. Flow
-$139M
Cap. Flow %
-4.39%
Top 10 Hldgs %
44.56%
Holding
148
New
26
Increased
24
Reduced
52
Closed
18

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$22.1M
2
SMLR
Semler Scientific
SMLR
+$18.4M
3
TSHA icon
Taysha Gene Therapies
TSHA
+$15.5M
4
FTCV
FinTech Acquisition Corp. V Class A Common Stock
FTCV
+$10.5M
5
IMAX icon
IMAX
IMAX
+$10.4M

Top Sells

Rank Stock Value
1
VG
Vonage Holdings Corporation
VG
+$18.9M
2
LNW
Light & Wonder
LNW
+$15.3M
3
PWP icon
Perella Weinberg Partners
PWP
+$13.7M
4
FTCVU
FinTech Acquisition Corp. V Unit
FTCVU
+$13.1M
5
PAYO icon
Payoneer
PAYO
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.07%
2 Consumer Discretionary 8.35%
3 Technology 4.89%
4 Financials 4.19%
5 Communication Services 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXPE icon
26
DXP Enterprises
DXPE
$2.99B
$34.8M 1.1%
1,175,806
-103,377
-8% -$3.17M
IMTX icon
27
Immatics
IMTX
$1.33B
$34.4M 1.08%
2,647,449
+102,827
+4% +$1.31M
IMAX icon
28
CALL
IMAX
IMAX
$2.81B
$34.2M 1.08%
1,800,000
+1,200,000
+200% +$19.9M
SFT
29
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$31.1M 0.98%
447,422
-52,771
-11% -$4.23M
KROS icon
30
Keros Therapeutics
KROS
$212M
$30.1M 0.95%
760,383
+161,503
+27% +$5.75M
ALTG icon
31
Alta Equipment Group
ALTG
$237M
$26.6M 0.84%
1,940,082
-114,207
-6% -$1.5M
FBIO icon
32
Fortress Biotech
FBIO
$91.4M
$26.2M 0.83%
542,720
+40,775
+8% +$1.99M
RDVT icon
33
Red Violet
RDVT
$926M
$25.8M 0.81%
1,000,000
– –
IMXI icon
34
International Money Express
IMXI
$356M
$25.6M 0.81%
1,533,660
-188,580
-11% -$3.16M
RHP icon
35
PUT
Ryman Hospitality Properties
RHP
$7.57B
$25.1M 0.79%
+300,000
New +$23.9M
TSHA icon
36
Taysha Gene Therapies
TSHA
$1.83B
$23.3M 0.73%
1,249,309
+817,237
+189% +$15.5M
APEN
37
DELISTED
Apollo Endosurgery, Inc.
APEN
$22.8M 0.72%
2,514,328
+196,837
+8% +$1.69M
IWM icon
38
iShares Russell 2000 ETF
IWM
$81.5B
$21.8M 0.69%
+99,593
New +$22.1M
RMR icon
39
The RMR Group
RMR
$335M
$21M 0.66%
626,751
-34,233
-5% -$1.3M
VG
40
CALL
DELISTED
Vonage Holdings Corporation
VG
$20.1M 0.64%
1,250,000
– –
CRIS icon
41
Curis
CRIS
$7.13M
$19.3M 0.61%
6,156
+947
+18% +$2.96M
AUTL
42
Autolus Therapeutics
AUTL
$551M
$19.2M 0.61%
2,936,791
+1,143,291
+64% +$7.22M
SMLR
43
DELISTED
Semler Scientific
SMLR
$18.2M 0.57%
+145,419
New +$18.4M
RDI icon
44
Reading International Class A
RDI
$35.2M
$17.6M 0.55%
3,470,315
+1,153,576
+50% +$6.09M
PTON icon
45
CALL
Peloton Interactive
PTON
$2.42B
$17.4M 0.55%
200,000
– –
PAYA
46
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$16.1M 0.51%
1,481,096
-13,020
-0.9% -$140K
DHX icon
47
DHI Group
DHX
$158M
$16.1M 0.51%
3,375,606
-403,294
-11% -$1.58M
APTO
48
DELISTED
Aptose Biosciences, Inc.
APTO
$16M 0.51%
16,346
-413
-2% -$517K
AKU
49
DELISTED
Akumin Inc
AKU
$15.7M 0.49%
6,320,740
+100,000
+2% +$274K
AVTX icon
50
Avalo Therapeutics
AVTX
$1.06B
$15.2M 0.48%
2,414
+218
+10% +$1.77M
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Nantahala Capital Management held 148 positions worth $3.17B, down 9.8% from $3.52B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Nantahala Capital Management withdrew a net $139M in Q3 2021, closing 18 positions and reducing 52 holdings. Its most notable exit was FinTech Acquisition Corp. V Unit, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Nantahala Capital Management opened a new position in iShares Russell 2000 ETF worth $21.8M.

  • Nantahala Capital Management's largest Q3 2021 buy was iShares Russell 2000 ETF: 99,593 shares worth $21.8M.
  • Nantahala Capital Management added most to Taysha Gene Therapies in Q3 2021, an estimated $15.5M increase.
  • Nantahala Capital Management's biggest Q3 2021 reduction was Vonage Holdings Corporation, cutting an estimated $18.9M.
  • Nantahala Capital Management fully exited FinTech Acquisition Corp. V Unit in Q3 2021, selling an estimated $13.1M.
  • Nantahala Capital Management's ten largest holdings make up 45% of its $3.17B portfolio in Q3 2021.
  • Nantahala Capital Management opened 26 new positions and closed 18 in Q3 2021.
  • Nantahala Capital Management's portfolio value fell 9.8% quarter-over-quarter to $3.17B.

Based on Nantahala Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.